Transthyretin Amyloidosis Drug Market Key Drivers and Forecast 2025-2032
Transthyretin Amyloidosis Drug Market Market Drivers And Trends The Transthyretin Amyloidosis Drug Market was valued at USD 2.6 Billion in 2022 and is projected to reach USD 6.8 Billion by 2030, growing at a CAGR of 12.8% from 2024 to 2030. The market growth is primarily driven by the increasing global prevalence of transthyretin amyloidosis […]
Continue Reading